Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.
about
Coxsackievirus A16: epidemiology, diagnosis, and vaccine.Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps.Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified.Construction and characterization of an infectious clone of coxsackievirus A16.The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection.Analytical methods for the detection of viruses in food by example of CCL-3 bioagents.Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral CapsidsAntibodies to P-selectin glycoprotein ligand-1 block dendritic cell-mediated enterovirus 71 transmission and prevent virus-induced cells death.Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor.Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice.Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level.Development of a dot-immunoenzyme filtration assay for the detection of enterovirus 71 antigen in human serum via immunoglobulin M.A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
P2860
Q34290731-493E4D26-91BC-4ECE-8561-D5545D112D7EQ34603692-DAA6B870-4731-4E30-AF09-6DB4EF748D9FQ34921442-FEA6A2F3-5168-41D1-B4D1-4623E4EF909EQ35067894-46D2D386-658A-4C6C-B2D5-6E9F48B26FF7Q35768977-2EB28ADD-CF46-4731-AA48-24A46B664A15Q37716692-D73CA4C2-A218-43CA-8378-28084B9695CDQ38004823-5A34AF9E-258F-429A-8716-DD8C1EAB709EQ38763206-F7D52D39-2CE9-4CA6-A556-D35C6CB26505Q38833043-57E050D5-7C0E-4BCA-A52B-510DA6ED5652Q40107981-95E971B4-B501-4496-ACBD-F651C1AA0741Q47555463-EAAF7A91-EA0A-428C-9DE3-38514FAFD159Q47557837-FA94B8E2-6698-4A5A-ADBA-591F8A80CB8EQ54296040-6BC8AD2E-B9D2-436A-BDEB-36117BF6AD86Q55099892-2C14E32B-E1B1-41C7-8F67-9CDEEFF6674D
P2860
Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Detection, characterization an ...... inant capsid subunit proteins.
@en
Detection, characterization an ...... inant capsid subunit proteins.
@nl
type
label
Detection, characterization an ...... inant capsid subunit proteins.
@en
Detection, characterization an ...... inant capsid subunit proteins.
@nl
prefLabel
Detection, characterization an ...... inant capsid subunit proteins.
@en
Detection, characterization an ...... inant capsid subunit proteins.
@nl
P2093
P1476
Detection, characterization an ...... binant capsid subunit proteins
@en
P2093
Qibin Leng
Qingwei Liu
Zhiqiang Ku
P304
P356
10.1016/J.JVIROMET.2011.01.016
P50
P577
2011-02-03T00:00:00Z